Top Investment Manager Reveals Q2 2024 Results for Ortobiologibolaget Ossdsign, Spelutvecklaren Starbreeze, Bico, and Bahnhof
Ortobiologibolaget Ossdsign reported a operating result of -15.3 million SEK (-21.3) in the second quarter of 2024. Revenue increased to 29.7 million SEK (24.0).
Spelutvecklaren Starbreeze disclosed an operating result before depreciation and amortization (ebitda result) of 8.1 million SEK for the second quarter of 2024 (14.1). Net revenue amounted to 40.2 million SEK (43.2).
Bico, specializing in 3D bioprinters and bioautomation, reported an adjusted ebitda result of 45.7 million SEK (10.9) for the second quarter of 2024. Net revenue stood at 534 million SEK (537).
Internet operator Bahnhof announced an operating result of 62.6 million SEK (57.3) for the second quarter of 2024. Net revenue reached 501 million SEK (459).
Analysis: Ortobiologibolaget Ossdsign and Spelutvecklaren Starbreeze experienced mixed results in Q2 2024, with Ortobiologibolaget Ossdsign seeing an increase in revenue despite a negative operating result, while Spelutvecklaren Starbreeze faced challenges with a decrease in net revenue. On the other hand, Bico showed significant growth in both ebitda result and net revenue. Bahnhof also demonstrated a positive performance with an increase in both operating result and net revenue. Investors should closely monitor these companies for potential opportunities or risks in their investment portfolios.